1
Mark E Williamson, Jerry W Newbrough, Jeffrey P Castleberry, Steve W Stracener: Ambulatory infusion pump. Baxter International, Mark Buonaiuto, Paul C Flattery, Jay Nichols, January 9, 1996: US05482446 (221 worldwide citation)

A medical infusion pump (10) using a pump chamber cassette (86) has a housing (20,22) defining a pump chamber cassette receptacle (84) and a pump driving mechanism (250) for propelling liquid through the pump chamber cassette. A door (50) holds the pump chamber cassette (86) within the cassette rece ...


2
Mark E Williamson, Jerry W Newbrough, Robert L Anderson, Jeffrey P Castleberry, Warren P Heim, Steve W Stracener: Pump chamber and valve assembly. Baxter International, Francis C Kowalik, Mark Buonaiuto, Paul Flattery, September 3, 1996: US05551850 (172 worldwide citation)

A medical infusion pump (10) using a pump chamber cassette (86) has a housing (20,22) defining a pump chamber cassette receptacle (84) and a pump driving mechanism (250) for propelling liquid through the pump chamber cassette. A door (50) holds the pump chamber cassette (86) within the cassette rece ...


3
Joseph Wong, Irwin B Levine: In-line drug delivery device for use with a standard IV administration set and a method for delivery. Baxter International, Mark Buonaiuto, Paul C Flattery, Jeffrey C Nichols, January 16, 1996: US05484406 (52 worldwide citation)

A drug delivery device (250) is provided for coupling a container (260) including a beneficial agent (262) to the device (250). The device (250) includes a substantially hollow member for housing a solution (256) wherein the hollow member includes an upper section (254) having flexible walls and a l ...


4
Allan E Titus, Douglas G Johnson: Premixed famotidine formulation. Baxter International, Mark Buonaiuto, Monique Morneault, July 22, 1997: US05650421 (3 worldwide citation)

A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4.5 to about 8.0, and a shelf life greater than 30 days.


5
James E Kipp, Mark J Doty, Christine L Rebbeck, Jan Y Eilert: Amiodarone-containing parenteral administration. Baxter International, Mark Buonaiuto, Robert Diehl, November 12, 2002: US06479541

The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methane ...



Click the thumbnails below to visualize the patent trend.